Diabetic Nephropathic Market by Treatment Type (Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blocker, Diuretics, Calcium Channel Blocker, Renin Inhibitors, Connective Tissue Growth Factor Inhibitors, Antioxidant Inflammation Modulators, Monocyte Chemoattractant Protein Inhibitors, Endothelin-A Receptor Antagonist, G-Protein-Coupled Receptor, and Others): Global Opportunity Analysis and Industry Forecast, 2018–2025

Pages: NA
Oct 2020 | 600 Views
Author(s) : NA
Tables: NA
Charts: NA


Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Diabetic Nephropathic Market

Request Now !

Diabetes is a condition in which the blood sugar level is considerably high due to malfunctioning of the pancreas. Nephropathy refers to kidney damage or impairment. Diabetic nephropathy is a kidney glomerulus disease, which is one of the major complications in terms of morbidity and mortality for diabetic population. In early stages, the symptoms of diabetic nephropathy stay unknown. However, in later stages, major signs and symptoms occur, which include high blood pressure, ankle & leg swelling, vomiting, morning weakness, high level of blood urea nitrogen, increased albumin secretion in urine, nausea, and itching.


For treatment of diabetic nephropathy, disease modifying therapies that employ angiotensin II receptor blockers and angiotensin-converting enzyme inhibitors are used. ACE inhibitors and ARBs provide superior protection to the kidney. Losartan, candesartan, and irbesartan are major ARBs, while ACE inhibitors such as lisinopril, captopril, enalapril, and ramipril help to decrease the amount of protein in the urine. Increase in investment in R&D for drug discovery and rise in awareness of diabetes & kidney-related disorder treatment are the major factors that are anticipated to boost the growth of the global diabetic nephropathy market. For instance, the American Diabetes Association organize regular programs to create awareness among diabetic population, and ensures all the patients can get the knowledge, best treatment, and care for diabetes management.

Surge in prevalence of diabetes & obesity, increase in R&D investments in drug discovery & development, and rise in awareness about diabetes & kidney-related disorders are some of the major drivers of the global diabetic nephropathy market. On the other hand, stringent regulatory requirements and longer approval time for drugs as well as a lack of comprehensive therapeutic management for diabetic nephropathy restrain the growth of the market. On the contrary, rise in usage of combination therapy is witnessing increased popularity in the diabetic nephropathy market. This is attributed to increase in the diabetic population and rise in incidence rates of various kidney diseases, which are expected to offer lucrative opportunities for market expansion.

The diabetic nephropathy market is categorized based on treatment type and region. By treatment type, the market is segmented into ACE inhibitors, ARBs, diuretics, calcium channel blockers, renin inhibitors, connective tissue growth factor inhibitors, antioxidant inflammation modulators, monocyte chemoattractant protein inhibitors, endothelin-A receptor antagonist, G protein-coupled receptors, and others. Region wise, the report identifies and analyses the market size and predictions for North America, Europe, Asia-Pacific, and LAMEA.

The market is highly competitive in nature, with major players focused on creating awareness regarding the diabetic nephropathy. Major players in the diabetic nephropathy market host exhibition and seminars to display and promote the use of diabetic nephropathy for diverse medical applications. The prominent players in the market have adopted various strategies for development, such as product innovation, product launches & approvals, and investment in R&D for advancements in diabetic nephropathy, to sustain the competitive environment of the global diabetic nephropathy market. Some of the top key players operating in this market include Merck & Co, Bayer AG, Abbott, Sanofi, Novartis AG, Reata Pharmaceuticals, Pfizer Inc., AbbVie Inc., Eli Lilly and Company, and Mitsubishi Tanabe Pharma Corporation.


  • This report provides a detailed quantitative analysis of the current diabetic nephropathy market trends and diabetic nephropathy market forecast estimations from 2018 to 2025, which assists to identify the prevailing diabetic nephropathy market opportunities. 
  • Diabetic nephropathy market analysis includes analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.
  • A comprehensive analysis of the factors that drive and restrain the growth of the global diabetic nephropathy market is provided.
  • Region-wise and country-wise diabetic nephropathy market conditions are comprehensively analyzed in this report.
  • The projections in this report are made by analyzing the current diabetic nephropathy market trends and future market potential from 2018 to 2025 in terms of value.
  • An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.
  • Key market players within the diabetic nephropathy market are profiled in this report and their strategies are analyzed thoroughly, which helps to understand the competitive outlook of global diabetic nephropathy market.


By Treatment Type

  • Angiotensin-converting Enzyme Inhibitors
  • Angiotensin Receptor Blockers
  • Diuretics
  • Calcium Channel Blocker
  • Renin Inhibitor
  • Connective Tissue Growth Factor Inhibitors
  • Antioxidant Inflammation Modulators
  • Monocyte Chemoattractant Protein Inhibitors
  • Endothelin-A Receptor Antagonist
  • G protein-coupled Receptors
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • Australia
    • Japan
    • India
    • China
    • Rest of Asia-Pacific
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA


With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.


Start reading ,This title and over 12000 thousand more,available with Avenue Library,  T&C*

Reach out to us

Call us on
( U.S. - Canada toll free )
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at










Purchase Full Report of
Diabetic Nephropathic Market

  • Online Only
  • $3,456  $3,110
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840  $3,456
  • Restricted to one authorized user
  • One print only
  • Available in
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769  $5,192
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450  $5,805
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise

  • $8,995  $8,096
  • Unlimited
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
  • Company Profiles
  • Newly Added Content Access
  • 10 PDF
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Start reading.
    This title and over 12,000+ are available on the Avenue Library.  T&C*.

    Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD


Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers


Featured Reports


Featured Readings


Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts